Published in J Vasc Access on July 19, 2007
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int (2007) 3.52
[Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease]. Nefrologia (2008) 1.47
Compliance with mineral metabolism targets in haemodialysis patients: moving backwards? Blood Purif (2013) 1.40
[Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies]. An Med Interna (2001) 1.39
Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol (2000) 1.36
Changes in quality of life after renal transplantation. Am J Kidney Dis (1998) 1.31
Quality of life in dialysis patients. A spanish multicentre study. Spanish Cooperative Renal Patients Quality of Life Study Group. Nephrol Dial Transplant (1996) 1.09
Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron (1998) 1.05
Nephrologists of the Balkan countries meet across political frontiers and war fronts--an example to politicians! BANTAO: a new European medical association overcomes political obstacles. Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs. Nephrol Dial Transplant (1996) 1.05
Renal artery stenosis after kidney transplantation: diagnostic and therapeutic approach. Kidney Int Suppl (1998) 1.02
High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis (1990) 0.99
Report on management of renal failure in Europe, XXV, 1994. The child-adult interface. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant (1996) 0.98
[Visceral leishmaniasis in systemic lupus erythematosus]. Med Clin (Barc) (1987) 0.92
Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis. Nephrol Dial Transplant (2001) 0.91
Renal vascular disease in the elderly. Kidney Int Suppl (1998) 0.90
Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant (1996) 0.90
Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis (1996) 0.89
European best practice guidelines 14-16: inadequate response to epoetin. Nephrol Dial Transplant (2000) 0.89
European best practice guidelines 6-8: assessing and optimizing iron stores. Nephrol Dial Transplant (2000) 0.88
Progress in dialysis technology: membrane selection and patient outcome. Nephrol Dial Transplant (2000) 0.88
European best practice guidelines 1-4: evaluating anaemia and initiating treatment. Nephrol Dial Transplant (2000) 0.87
Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant (1995) 0.85
Report on management of renale failure in Europe, XXVI, 1995. The child-adult interface: a report on Alport's syndrome, 1975-1993. The ERA-EDTA Registry. Nephrol Dial Transplant (1996) 0.85
Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review. Transplantation (1998) 0.84
[Differences in health-related quality of life between male and female hemodialysis patients]. Nefrologia (2004) 0.84
European best practice guidelines 5: target haemoglobin. Nephrol Dial Transplant (2000) 0.83
Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1989) 0.82
Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena. Proc Eur Dial Transplant Assoc (1983) 0.79
Effects of antihypertensive therapy on progression of diabetic nephropathy. Kidney Int Suppl (1998) 0.79
Prevalence of hypertension in renal disease. Nephrol Dial Transplant (2001) 0.79
Acute kidney failure in the context of a Tako-Tsubo syndrome. Nefrologia (2011) 0.78
[Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)]. Nefrologia (2007) 0.78
[Prolonged acute renal failure and severe polyradiculopathy in ethylene glycol intoxication]. Nefrologia (2006) 0.78
Haemodialysis dose, extracellular volume control and arterial hypertension. Nephrol Dial Transplant (2001) 0.78
Transfusion-induced anergy: skin test as an index for pretransplant transfusions. Proc Eur Dial Transplant Assoc (1983) 0.78
High-sensitivity troponin T levels in kidney transplant recipients. Transplant Proc (2012) 0.77
[Pharmacogenetics of angiotensin system in non diabetic nephropathy]. Nefrologia (2005) 0.77
Serum calcium and parathyroid hormone derangements in rhabdomyolysis. Nephron (1989) 0.77
The non-casual relation between eosinophilia and thrombotic microangiopathy. Transfus Apher Sci (2012) 0.77
[Risk of cardiovascular disease associated to chronic renal disease. Prevalence and control degree of classical risk factors]. Nefrologia (2005) 0.76
[Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?]. Nefrologia (2001) 0.76
[Dialysis inclusion criteria and early mortality]. Nefrologia (2001) 0.76
Transplantation Report. 1: renal transplantation in recipients aged 60 years or older at time of grafting. The EDTA-ERA Registry. European Dialysis and transplant Association-European Renal Association. Nephrol Dial Transplant (1996) 0.75
Minimal change glomerular disease in association with a carcinoma of the esophagus. Nephron (1994) 0.75
L-Carnitine in dialysis, more than a commercial affair. Nephrol Dial Transplant (2000) 0.75
Membranoproliferative glomerulonephritis and hepatitis C virus infection. Nephron (1994) 0.75
Brachial-jugular polytetrafluoroethylene fistulas for hemodialysis. Am J Kidney Dis (1990) 0.75
Neonatal kidney grafts into adult recipients. Nephron (1991) 0.75
Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative. Am J Nephrol (1998) 0.75
Plasma exchange in the treatment of vascular rejection. Relationship between histological changes and therapeutic response. Transplant Proc (1987) 0.75
Acute renal failure and rhabdomyolysis following cocaine abuse. Nephron (1990) 0.75
[Temporary catheter at dialysis onset: quality indicator of pre-dialysis care]. Nefrologia (2006) 0.75
[Metabolic syndrome in patients with essential hypertension]. Nefrologia (2003) 0.75
Acquired immunodeficiency syndrome in dialysis. Nephron (1988) 0.75
[Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications]. Rev Clin Esp (1980) 0.75
[Association of papulous mucinosis and systemic lupus erythematosus with membranous glomerulonephritis]. Rev Clin Esp (1980) 0.75
[Partial recovery of renal function in mesangio-capillary glomerulonephritis after an unsuccessful kidney transplant]. Rev Clin Esp (1981) 0.75
[Clinical research based nephrology (bases for the constitution of an Evidence Based Nephrology Group in the Spanish Society of Nephrology)]. Nefrologia (2006) 0.75
[What features show patients referred for the first time to an outpatient nephrology clinic?]. Nefrologia (2005) 0.75
Acute renal failure after bacteraemia and endocarditis. Nephrol Dial Transplant (2001) 0.75
[Risk factors in the development and progression of end-stage renal failure, the 21st century epidemic]. Nefrologia (2001) 0.75
[Vasculitis in elderly patients associated to ANCA]. Nefrologia (2003) 0.75
[Renal arteriography during heart catheterization: 2 explorations with the price of one]. Nefrologia (2000) 0.75
[Bone disease in maintenance hemodialysis. Clinical, biochemical and radiological correlates]. Rev Clin Esp (1981) 0.75
[Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?]. An Med Interna (1998) 0.75
Tuberculous peritonitis in patients on CAPD. Contrib Nephrol (1991) 0.75
[Hyperparathyroidism after kidney transplant, its relation to kidney function and ionic calcium]. Rev Clin Esp (1980) 0.75
Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs. Nephrol Dial Transplant (2001) 0.75
[Why early referral to the nephrologist of patients with diabetic nephropathy is necessary?]. Rev Clin Esp (1999) 0.75
[Renal insufficiency is an important cardiovascular risk factor]. Nefrologia (2002) 0.75
[Evaluation of efficacy of darbepoetin alfa administered once monthly as treatment of anemia in predialysis patients with chronic kidney disease]. Nefrologia (2005) 0.75
[Control of arterial pressure in diabetic nephropathy]. Nefrologia (2001) 0.75
[Pre-dialysis vascular access. Does the evidence justify it?]. Nefrologia (2001) 0.75
[Why is an early referral to a consult with a nephrologist necessary for patients with diabetic nephropathy?]. Aten Primaria (1999) 0.75
[Cellular and humoral immunity in patients on hemodialysis]. Rev Clin Esp (1980) 0.75
[Renal and cardiovascular protection associated to antihypertensive treatment in the elderly]. Nefrologia (2002) 0.75
[Acute unilateral pulmonary edema in patients with chronic renal insufficiency]. Rev Clin Esp (1981) 0.75
[Cerebral moya-moya disease with bilateral kidney infarction (author's transl)]. Med Clin (Barc) (1981) 0.75
[Current features of antihypertensive drug treatment]. Rev Clin Esp (1999) 0.75
[Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment]. Rev Clin Esp (1982) 0.75
[Papulous mucinosis or scleromyxedema. Etiopathogenic, diagnostic and therapeutic aspects]. Rev Clin Esp (1980) 0.75